Hiatal Hernia
0
Pipeline Programs
5
Companies
4
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Oregon TherapeuticsFrance - Paris
1 programStudy of Paraesophageal Hernia Repair With Small Intestine SubmucosaN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
TELA BioOviTex Reinforced Tissue Matrix
Intuitive SurgicalBiosynthetic Mesh
Integra LifeSciencesSurgiMend Mesh
Oregon TherapeuticsStudy of Paraesophageal Hernia Repair With Small Intestine Submucosa
Clinical Trials (4)
Total enrollment: 490 patients across 4 trials
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
Start: Jul 2025Est. completion: Jul 2032173 patients
N/ARecruiting
Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair
Start: Jun 2024Est. completion: Jul 2030200 patients
N/ARecruiting
SurgiMend Mesh at the Hiatus
Start: Mar 2020Est. completion: Sep 20239 patients
N/ACompleted
Study of Paraesophageal Hernia Repair With Small Intestine Submucosa
Start: Sep 2008Est. completion: Dec 2009108 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 490 patients
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.